ProMIS Neurosciences Inc.
PMN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001374339
In the last 90 days, ProMIS Neurosciences Inc. insiders filed 1 open-market purchase and 0 sales; 27 institutions reported holding it in 13F filings for Q2 2026, worth $84.3M in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in ProMIS Neurosciences Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- +5 vs. Q2 2025
- Shares held
- 9.99M
- +1.57M (+18.7%) vs. Q2 2025
- Total value
- $4.25M
- +$172.0K (+4.2%) vs. Q2 2025
- New holders
- 8
- 4 more added
- Sold out
- 3
- 1 more reduced
1 institution that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PMN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $84.3M |
| Q1 2026 | 25 | $78.0M |
| Q4 2025 | 9 | $1.80M |
| Q3 2025 | 23 | $4.25M |
| Q2 2025 | 19 | $4.10M |
| Q1 2025 | 17 | $6.49M |
| Q4 2024 | 17 | $9.21M |
| Q3 2024 | 18 | $12.6M |
| Q2 2024 | 16 | $4.90M |
| Q1 2024 | 16 | $6.46M |
| Q4 2023 | 15 | $3.85M |
| Q3 2023 | 14 | $5.61M |
| Q2 2023 | 13 | $723.8K |
| Q1 2023 | 12 | $889.2K |
| Q4 2022 | 13 | $824.5K |
| Q3 2022 | 13 | $1.13M |
| Q2 2022 | 2 | $468.0K |
| Q1 2022 | 2 | $8.00K |
| Q4 2021 | 2 | $9.00K |
| Q3 2021 | 3 | $14.0K |
| Q2 2021 | 3 | $17.0K |
| Q1 2021 | 3 | $17.0K |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding ProMIS Neurosciences Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 68 | $29 | 0.00% | +68 | New |
| National Bank of Canada | 88 | $37 | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 254 | $106 | 0.00% | +254 | New |
| North Star Investment Management Corp. | 500 | $212 | 0.00% | +500 | New |
| TD Waterhouse Canada Inc. | 940 | $422 | 0.00% | +807+606.8% | Added |
| Bank of America Corp | 1,666 | $708 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 2,506 | $1.06K | 0.00% | +2,506 | New |
| Royal Bank of Canada | 5,487 | $2.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 9,000 | $4.77K | 0.00% | +9,000 | New |
| Commonwealth Equity Services, LLC | 11,447 | $5.00K | 0.00% | 00.0% | Unchanged |
| Claret Asset Management Corp | 11,330 | $5.00K | 0.00% | 00.0% | Unchanged |
| Scotia Capital Inc. | 12,122 | $5.15K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 18,428 | $7.83K | 0.00% | +18,428 | New |
| Howard Financial Services, Ltd. | 26,042 | $11.1K | 0.00% | 00.0% | Unchanged |
| Ieq Capital, LLC | 26,042 | $11.1K | 0.00% | 00.0% | Unchanged |
| Fiduciary Trust Co | 28,583 | $12.1K | 0.00% | 00.0% | Unchanged |
| Bank of Montreal | 30,366 | $13.1K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 68,057 | $28.0K | 0.00% | +68,057 | New |
| XTX Topco Ltd | 67,687 | $28.8K | 0.00% | +67,687 | New |
| Citadel Advisors LLC | 170,079 | $72.3K | 0.00% | +106,650+168.1% | Added |
| Sphera Funds Management Ltd. | 295,187 | $125.5K | 0.03% | −1,604,110−84.5% | Reduced |
| Armistice Capital, LLC | 2,974,518 | $1.26M | 0.04% | +836,622+39.1% | Added |
| Ally Bridge Group (NY) LLC | 6,233,497 | $2.65M | 2.22% | +4,899,069+367.1% | Added |
| Great Point Partners LLC | 0 | $0 | 0.00% | −2,645,128−100.0% | Sold out |
| Allostery Investments LP | 0 | $0 | 0.00% | −155,720−100.0% | Sold out |
| Kingsview Wealth Management, LLC | 0 | $0 | 0.00% | −31,062−100.0% | Sold out |
| Graypoint LLC | – | – | – | – | Not filed |